Trends in Species Distribution and Susceptibility of Bloodstream Isolates of Candida Collected in Monterrey, Mexico, to Seven Antifungal Agents: Results of a 3-Year (2004 to 2007) Surveillance Study

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Microbiology

• Publication date

  2008-07-16

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1128/JCM.00937-08PMID 18632907PMCID PMC2546732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

  2009cited by this paper
• Reference method for broth dilution antifungal susceptibility testing of yeasts : Third informational supplement

  2008cited by this paper
• Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers

  2006cited by this paper
• Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

  2006cited by this paper
• Candidemia in Norway (1991 to 2003): Results from a Nationwide Study

  2006cited by this paper
• Invasive Candida species infections: a 5 year population-based assessment.

  2005cited by this paper
• Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical Isolates

  2004influential reference
• Has the Epidemiology of Nosocomial Candidemia Changed?

  2004cited by this paper
• Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

  2004cited by this paper
• Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.

  2004cited by this paper
• Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location

  2003cited by this paper
• Attributable mortality of nosocomial candidemia, revisited.

  2003cited by this paper
• Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study

  2002cited by this paper
• NATIONAL NOSOCOMIAL INFECTIONS SURVEILLANCE SYSTEM H. SECULAR TREND OF HOSPITAL-ACQUIRED CANDIDEMIA AMONG INTENSIVE CARE UNIT PATIENTS IN THE UNITED STATES DURING 1989-1999

  2002cited by this paper
• Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility

  2002cited by this paper
• Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.

  2001cited by this paper
• Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

  2000cited by this paper
• Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

  1999cited by this paper
• Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.

  1999cited by this paper
• National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units.

  1999cited by this paper
• Trends in Antifungal Use and Epidemiology of Nosocomial Yeast Infections in a University Hospital

  1999cited by this paper
• Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

  1998cited by this paper
• National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

  1998cited by this paper
• Emergence of Candida parapsilosis as the predominant species causing candidemia in children.

  1998cited by this paper
• National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic.

  1998cited by this paper
• International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program

  1998cited by this paper
• Thirteen-Year Evolution of Azole Resistance in Yeast Isolates and Prevalence of Resistant Strains Carried by Cancer Patients at a Large Medical Center

  1998cited by this paper
• The epidemiology of hematogenous candidiasis caused by different Candida species.

  1997cited by this paper
• The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

  1996cited by this paper
• Importance of Candida species other than C. albicans as pathogens in oncology patients.

  1995cited by this paper
• Hospital-acquired candidemia. The attributable mortality and excess length of stay.

  1988cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• Antifungal Susceptibility and Resistance-Associated Gene Expression in Nosocomial Candida Isolates

  2025influential citation
• Antibiofilm sustainable strategies: pomegranate extract from agri-food waste as a natural antifungal against emerging Candida pathogens

  2025cites this paper
• The microbiology, epidemiology, risk factors, and clinical therapy of candidemia in burn patients hospitalized in Velayat Teaching Hospital, Rasht, northern Iran

  2024cites this paper
• Candida Variety in the Oral Cavity of Mexican Subjects with Type 2 Diabetes Mellitus and TLR2 Gene Expression

  2024cites this paper
• Ascomycetes yeasts: The hidden part of human microbiome.

  2024cites this paper
• Prevalence and Species Distribution of Candida Clinical Isolates in a Tertiary Care Hospital in Ecuador Tested from January 2019 to February 2020

  2024cites this paper
• Candida bloodstream infection in patients with cancer: A retrospective analysis of an 11-year period.

  2023cites this paper
• Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms

  2022cites this paper
• Clinical, epidemiological, and mycological features of patients with candidemia: Experience in two tertiary referral centers in Iran

  2022cites this paper
• Comparative Analysis of Epidemiological and Clinical Characteristics Between Invasive Candida Infection versus Colonization in Critically Ill Patients in a Tertiary Hospital in Anhui, China

  2022cites this paper
• Active Flavonoids from Colubrina greggii var. greggii S. Watson against Clinical Isolates of Candida spp.

  2021cites this paper
• Increase of Non-albicans Candida Species and Their Antifungal Susceptibility in Intensive Care Unit Patients (Mexico)

  2021influential citation
• Candida albicans and Abortion

  2021cites this paper
• Virulence Factors as Promoters of Chronic Vulvovaginal Candidosis: A Review

  2021cites this paper
• Molecular epidemiology, risk factors, species distribution, antifungal susceptibility and outcome of candidemia in the capital of Iran: a prospective study

  2020cites this paper
• Neonatal invasive candidiasis: A poorly understood entity

  2019cites this paper
• S0950268819001638jra 1..8

  2019cites this paper
• Antifungal activity of carvacrol and antifungal agent combinations against non-albicans Candida species

  2019cites this paper
• Geographic Tongue - Does Candida Play a Role in its Pathogenesis

  2019cites this paper
• In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid

  2019cites this paper
• Subgingival areas as potential reservoirs of different Candida spp in type 2 diabetes patients and healthy subjects

  2019cites this paper
• Promising alternative therapeutics for oral candidiasis.

  2019cites this paper
• FTIR and Raman Spectroscopy-Based Biochemical Profiling Reflects Genomic Diversity of Clinical Candida Isolates That May Be Useful for Diagnosis and Targeted Therapy of Candidiasis

  2019cites this paper
• Epidemiology, risk factors and outcomes of Candida albicans vs. non-albicans candidaemia in adult patients in Northeast China

  2019cites this paper
• An etiological and antifungal profile of candidemia in children

  2019cites this paper
• Characterization of non - albicans Candida species involved in human infections

  2019cites this paper
• In vitro virulence determinants, comparative pathogenicity of Diutina (Candida) mesorugosa clinical isolates and literature review of the D. rugosa complex

  2019cites this paper
• Oral Infectious Diseases

  2018cites this paper
• Presence of Different Candida Species at Denture Wearers With Type 2 Diabetes and Clinically Healthy Oral Mucosa-Pilot Study

  2018cites this paper
• Molecular Discrimination of the Candida parapsilosis Species Complex via SADH Gene Analysis and Evaluation of Proteinase Activity Among the Isolates

  2018influential citation
• Anti-fungal and Anti-Mycobacterial activity of plants of Nuevo Leon, Mexico.

  2017cites this paper
• Factors associated with nosocomial fungal sepsis among patients in the paediatric intensive care unit at the Chris Hani Baragwanath academic hospital

  2017cites this paper
• Candida Species Distribution and Antifungal Susceptibility Testing According to EUCAST and New vs. Old CLSI Clinical Breakpoints: a Six-Year Prospective Candidemia Survey from the Fungal Infection Network of Switzerland (FUNGINOS)

  2017cites this paper
• Association between Candida biofilm-forming bloodstream isolates and the clinical evolution in patients with candidemia: An observational nine-year single center study in Mexico.

  2017cites this paper
• [Epidemiology and antifungal susceptibility of species producing candidemia in Valdivia, Chile].

  2017cites this paper
• Current status of the etiology of candidiasis in Mexico.

  2017cites this paper
• Molecular detection of candida species from hospitalized patient’s specimens.

  2017cites this paper
• Identification of medically important Candida species by polymerase chain reaction-restriction fragment length polymorphism analysis of the rDNA ITS1 and ITS2 regions

  2017cites this paper
• Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.

  2017cites this paper
• Candidemias en pediatría: distribución de especies y sensibilidad a los antifúngicos

  2017cites this paper
• [Candidemia in Pediatrics: Species distribution and antifungal susceptibility].

  2017cites this paper
• Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers

  2017cites this paper
• New Eugenol Glucoside‐based Derivative Shows Fungistatic and Fungicidal Activity against Opportunistic Candida glabrata

  2016cites this paper
• Detection of Aflatoxin in Aspergillus Species Isolated from Immunocompromised Hospitalized Patients

  2016cites this paper
• Prevalence of Vulvovaginal Candidiasis in Pregnancy

  2016cites this paper
• Potential of Ravuconazole and its Prodrugs as the New OralTherapeutics for Onychomycosis.

  2016cites this paper
• Fungal Biofilms and related infections

  2016cites this paper
• Efficacy and safety of itraconazole use in infants

  2016cites this paper
• Epidemiological Characterization of Opportunistic Mycoses between the Years 2006 and 2010 in Korea.

  2016cites this paper
• Disinfectants to Fight Oral Candida Biofilms.

  2016cites this paper
• Propolis: a potential natural product to fight Candida species infections.

  2016cites this paper
• Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms

  2016cites this paper
• Recurrent Vulvovaginal Candidiasis Causing Cytological Change : A Study of 1000 Cases to Detect Association with Malignancy

  2016cites this paper
• Distribution of Candida Species and Molecular Typing of C. albicans Isolates in a Mexico City Tertiary Care Hospital from 2011 to 2013

  2016cites this paper
• Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: Correlation between cell surface hydrophobicity and biofilm forming activities.

  2015cites this paper
• Utility of Chromagar Medium for Antifungal Susceptibility Testing of Candida Species Against Fluconazole and Voriconazole in Resource Constrained Settings

  2015cites this paper
• Fluconazole susceptibility of 3,056 clinical isolates of Candida species from 2005 to 2009 in a tertiary-care hospital

  2015cites this paper
• Clinico-microbiological study of candidemia in a tertiary care hospital of southern part of India

  2015cites this paper
• Clinical isolates of Candida albicans, Candida tropicalis, and Candida krusei have different susceptibilities to Co(II) and Cu(II) complexes of 1,10-phenanthroline

  2015cites this paper
• [Clinical usefulness of triazole derivatives in the management of fungal infections].

  2015cites this paper
• Candida parapsilosis, C. orthopsilosis y C. metapsilosis: epidemiología de las candidemias, patrones de sensibilidad y mecanismos de resistencia a las equinocandinas

  2015cites this paper
• La utilidad clínica de los derivados triazólicos en el tratamiento de las infecciones fúngicas

  2015cites this paper
• Oral candida in HIV positive women: influence of oral hygiene, clinical and social factors on the carriage rates and the influence of virulence of the organism on the development of clinical infection

  2014cites this paper
• Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.

  2014cites this paper
• Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Sw

  2014cites this paper
• Colonización por Candida en una unidad de cuidados intensivos neonatales

  2014cites this paper
• In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates

  2014cites this paper
• El silenciamiento local controla la respuesta al estrés oxidante y la resistencia multifarmacológica de Candida glabrata

  2014cites this paper
• Antifungal susceptibility profile of yeast isolates from sterile sites at a tertiary hospital in South Africa

  2014cites this paper
• Phenotypic and molecular genetic profiles of fluconazole and voriconazole sensitive versus resistant candida spp

  2014cites this paper
• Antifungal activity of phenolic compounds identified in flowers from North Eastern Portugal against Candida species.

  2014cites this paper
• Activities of amphotericin B, fluconazole and voriconazole against Candida bloodstream isolates determined by broth microdilution and disk diffusion methods

  2014cites this paper
• Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period

  2014cites this paper
• Evaluation of in vivo pathogenicity of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis with different enzymatic profiles in a murine model of disseminated candidiasis.

  2014cites this paper
• Surveillance of Candida spp Bloodstream Infections: Epidemiological Trends and Risk Factors of Death in Two Mexican Tertiary Care Hospitals

  2014cites this paper
• Resistant to Fluconazole Fluconazole on Candida tropicalis Synergistic Effects of Amiodarone and

  2014cites this paper
• Trends in antifungal susceptibility of Candida species--one year observation.

  2014cites this paper
• Epidemiology of candidaemia and invasive candidiasis. A changing face.

  2014cites this paper
• Aspartyl proteinase, phospholipase, esterase and hemolysin activities of clinical isolates of the Candida parapsilosis species complex.

  2013cites this paper
• Ozone application for preventing fungal infection in diabetic foot ulcers.

  2013cites this paper
• Antifungal activity and detailed chemical characterization of Cistus ladanifer phenolic extracts

  2013cites this paper
• Prevalence of Vaginal Candidiasis and Determination of the Occurrence of Candida Species in Pregnant Women Attending the Antenatal Clinic of Thika District Hospital, Kenya

  2013cites this paper
• Identification and Susceptibility Profile of Vaginal Candida Species to Antifungal Agents among Pregnant Women Attending the Antenatal Clinic of Thika District Hospital, Kenya

  2013cites this paper
• Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.

  2013cites this paper
• Synergistic Effects of Amiodarone and Fluconazole on Candida tropicalis Resistant to Fluconazole

  2013cites this paper
• Synergistic Effect of the Flavonoid Catechin, Quercetin, or Epigallocatechin Gallate with Fluconazole Induces Apoptosis in Candida tropicalis Resistant to Fluconazole

  2013cites this paper
• Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi‐centre study

  2012cites this paper
• Epidemiology of Invasive Fungal Infections in Latin America

  2012cites this paper
• Occurrence of killer Candida glabrata clinical isolates

  2012cites this paper
• Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance.

  2012cites this paper
• Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India

  2012cites this paper
• Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico.

  2012cites this paper
• Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.

  2012cites this paper
• Species distribution and in vitro susceptibility to three antifungal triazoles of clinical Candida isolates from a five-year nation-wide survey in Japan

  2012cites this paper
• Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting

  2012cites this paper
• In vitro Susceptibilities of Iranian Clinical non-albicans Candida species to Caspofungin and Ketoconazole

  2012cites this paper
• ntifungal activity and detailed chemical characterization of Cistus ladanifer henolic extracts

  2012cites this paper
• Isolation, identification and susceptibility profile of candida species to antifungal agents in pregnant women in Thika District Hospital, Kenya

  2012cites this paper
• Candida parapsilosis, una amenaza desafiante

  2012cites this paper
• The Epidemiology of Invasive Candidiasis

  2012cites this paper